Endothelial progenitor cell biology in ankylosing spondylitis

International Journal of Rheumatic Diseases

Volumn 18, Issue 3, 2015, Pages 336-340

[No Author Info available]

Author keywords

Ankylosing spondylitis; Endothelial progenitor cells; Inflammation; Vascular damage

Indexed keywords

C REACTIVE PROTEIN; CD133 ANTIGEN; CD34 ANTIGEN; AUTACOID; BIOLOGICAL MARKER; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ADOLESCENT; ADULT; ANKYLOSING SPONDYLITIS; ANTIGEN EXPRESSION; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; BLOOD SAMPLING; CELL POPULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOLOGY; DISEASE ACTIVITY; DISEASE DURATION; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PRIORITY JOURNAL; BLOOD; CASE CONTROL STUDY; CELL COUNT; CELL SEPARATION; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PROCEDURES; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, CD34; BIOMARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CELL COUNT; CELL SEPARATION; ENDOTHELIAL PROGENITOR CELLS; FEMALE; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PEPTIDES; PHENOTYPE; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; YOUNG ADULT;

EID: 84928541571     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12487     Document Type: Article

References (21)

1. Ablin JN, Goldstein Z, Aloush V et al. (2009) Normal levels and function of endothelial progenitor cells in patients with psoriatic arthritis. Rheumatol Int 29, 257-62.
2. Nolta JA, Jordan CT (2001) Spotlight on hematopoietic stem cells: looking beyond dogma. Leukemia 15, 1677-80.
3. Distler JH, Beyer C, Schett G, Luscher TF, Gay S, Distler O (2009) Endothelial progenitor cells: novel players in the pathogenesis of rheumatic diseases. Arthritis Rheum 60, 3168-79.
4. Devaraj S, Jialal I (2011) Dysfunctional endothelial progenitor cells in metabolic syndrome. Exp Diabetes Res 2012, 1-5.
5. Hill JM, Zalos G, Halcox JP et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348, 593-600.
6. Radenkovic M, Stojanovic M, Potpara T, Prostran M (2013) Therapeutic approach in the improvement of endothelial dysfunction: the current state of the art. Biomed Res Int 2013, 1-12.
7. Grisar J, Aletaha D, Steiner CW et al. (2005) Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 111, 204-11.
8. Herbrig K, Haensel S, Oelschlaegel U, Pistrosch F, Passauer J (2006) Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells. Ann Rheum Dis 65, 157-63.
9. Westerweel PE, Luijten RK, Hoefer IE, Koomans HA, Derksen RH, Verhaar MC (2007) Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus. Ann Rheum Dis 66, 865-70.
10. Deng XL, Li XX, Liu XY, Sun L, Liu R (2010) Comparative study on circulating endothelial progenitor cells in systemic lupus erythematosus patients at active stage. Rheumatol Int 30, 1429-36.
11. Zhu S, Evans S, Yan B et al. (2008) Transcriptional regulation of Bim by FOXO3a and Akt mediates scleroderma serum-induced apoptosis in endothelial progenitor cells. Circulation 118, 2156-65.
12. Del Papa N, Quirici N, Soligo D et al. (2006) Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 54, 2605-15.
13. Vander LS, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27, 361-8.
14. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21, 2286-91.
15. Calin A, Garrett S, Whitelock H et al. (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21, 2281-5.
16. Allanore Y, Batteux F, Avouac J, Assous N, Weill B, Kahan A (2007) Levels of circulating endothelial progenitor cells in systemic sclerosis. Clin Exp Rheumatol 25, 60-6.
17. Asahara T, Murohara T, Sullivan A et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-7.
18. Davis J (2011) Ankylosing spondylitis significantly raises heart risks. http://www.arthritistoday.org/news/heart-disease-ankylosing-spondylitis151.php.
19. Fadini GP, Tognon S, Rodriguez L et al. (2009) Low levels of endothelial progenitor cells correlate with disease duration and activity in patients with Behçet's disease. Clin Exp Rheumatol 2, 814-21.
20. Verma S, Kuliszewski MA, Li SH et al. (2004) C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109, 2058-67.
21. Syngle A, Vohra K, Sharma A, Kaur L (2010) Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-alpha blockade. Clin Rheumatol 29, 763-70.